Welcome to our dedicated page for Burcon Nutrascience news (Ticker: BRCNF), a resource for investors and traders seeking the latest updates and insights on Burcon Nutrascience stock.
Burcon NutraScience Corporation (BRCNF) is a leader in plant-based protein innovation, developing cutting-edge ingredients for global food systems. This news hub provides investors and industry professionals with timely updates on financial developments, technological breakthroughs, and strategic partnerships driving sustainable nutrition solutions.
Access authoritative reporting on BRCNF's regulatory filings, product commercialization efforts, and intellectual property expansions. Our curated news collection covers essential updates including quarterly earnings, new patent grants, manufacturing scale-up announcements, and sustainability initiatives within the plant-protein sector.
Bookmark this page for streamlined access to BRCNF's evolving market position and technical advancements. Stay informed about developments impacting the growing US$18 billion plant-based ingredients market through verified corporate communications and objective industry analysis.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has launched its Puratein® canola protein for the egg replacement market. This product offers food manufacturers a sustainable and cost-effective alternative to eggs, particularly for use in baked goods. The launch comes amid surging egg prices due to supply challenges and avian influenza outbreaks.
Burcon's canola protein isolate, with over 90% protein purity, has demonstrated the ability to replace up to 100% of powdered and shelled eggs, delivering cost-in-use savings of 20-30%. The product not only provides superior functionality and price stability but also offers a vegan-friendly option for consumers. This development opens up new possibilities for creating superior, more sustainable plant-based alternatives in the food industry.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed the process validation phase of a contract research project for a leading industry peer. This achievement showcases Burcon's technical capabilities and expertise in plant-based proteins. The project, which involved validating a food ingredient process, is now ready for scale-up.
Kip Underwood, Burcon's CEO, emphasized that collaboration is part of their market engagement strategy and creates new business opportunities. Randy Willardsen, Senior VP of Process, expressed readiness for further collaborations in the plant-based protein market.
Burcon continues to leverage its expertise through contract services, with additional projects in the pipeline. The company offers innovative processing solutions to companies looking to innovate and scale in the alternative protein market.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) held its 2024 annual general and special meeting on September 18, 2024. All eight nominees proposed for the board of directors were elected. Shareholders approved the appointment of KPMG LLP as auditors, the warrants issued to John A. Vassallo, and authorized the board to effect a potential share consolidation.
James Pekar, with over 30 years of experience in the dairy and food industry, was elected as a new director. Pekar founded First Choice Ingredients, which he sold to DSM for US$460 million in 2021. He currently holds approximately 2.2% of Burcon's outstanding common shares. Dr. Lorne Tyrrell retired from the board and did not stand for re-election.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a leader in plant-based protein development, announces CEO Kip Underwood's participation in the Protein Industries Canada Annual Conference on September 11, 2024. Underwood will be a panelist in the session 'Driving Innovative IP in Canada's Competitive Landscape,' discussing topics such as capturing innovation value, fostering legal clarity in collaboration, and expanding beyond Canadian borders.
The conference, themed 'Progress and Prosperity,' brings together industry leaders and innovators to share insights on the future of value-added agriculture. Underwood emphasizes the importance of intellectual property as the foundation of Burcon's innovative protein technologies, highlighting the company's commitment to advancing the plant-based protein industry.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a global technology leader in plant-based protein development, has announced details for its upcoming virtual Annual General and Special Meeting (AGM) scheduled for September 18, 2024, at 10:00 am Pacific Time. Shareholders can attend the AGM and view the company's presentation via a provided webcast link.
The company has mailed out Meeting Materials, including the Notice of Meeting, Management Proxy Circular, and Form of Proxy, on or around August 12, 2024. Shareholders are encouraged to vote in advance by 10:00 am Pacific Time on September 16, 2024. Only registered shareholders and appointed proxyholders can vote during the AGM. Shareholders can submit questions in advance to plam@burcon.ca, which will be addressed during CEO Kip Underwood's presentation.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed a commercial production campaign for its premium hemp and canola protein isolates. The company has refined its process to ensure exceptional purity, flavor, and functionality while maintaining consistent quality. Burcon's proteins are expected to play a key role in helping companies bring great-tasting, healthy plant-based foods to market.
Burcon's offerings include a 95% Hempseed Protein Isolate, ideal for beverages, dairy alternatives, protein bars, and nutritional supplements, and Puratein® C Canola Protein Isolate, which is nutritionally complete with a Protein Digestibility-Corrected Amino Acid Score of 1. Puratein® C is highly soluble across a broad pH range, suitable for various applications including egg protein replacement.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) reported results for the fiscal first quarter ended June 30, 2024. The company achieved its first commercial protein sale, marking a significant milestone. Burcon launched a high purity, nutritionally complete canola protein and expanded US investor outreach by trading shares on the OTCQB Venture Market. The company reported revenues of $0.2 million from hemp protein isolate sales and contract research services, compared to no revenues in the same period last year. Burcon reported a net loss of $1.9 million or $0.01 per share, unchanged from the previous year. Cash balances totaled $2.2 million as of June 30, 2024, down from $4.2 million on March 31, 2024.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF), a leader in plant-based protein development, has announced its fiscal 2025 first quarter conference call scheduled for August 14, 2024, at 5:00 p.m. Eastern time. The company will discuss financial results for the quarter ended June 30, 2024, which will be released prior to the call.
CEO Kip Underwood expressed optimism about Burcon's transition from a technology creator to a profit-generating innovator. The company is focusing on executing a capital-light strategy and bringing its plant-based protein ingredients to market. Investors can participate in the live call or access the webcast through Burcon's website.
Burcon NutraScience (TSX: BU) (OTCQB: BRCNF) has successfully completed its first commercial production of high-purity canola protein isolate at a partner manufacturer's facility. This achievement marks a significant milestone in the commercialization of Burcon's canola protein technology. The company has launched its Puratein® C canola protein isolate, which offers exceptional taste, nutrition, and functionality for food and beverage applications.
Key features of Puratein® C include:
- Over 90% protein purity
- Nutritionally complete amino acid profile
- Protein digestibility amino acid score (PDCAAS) of 1
- Neutral flavor
- High solubility across a broad pH range
- Superior foaming properties
Burcon plans to optimize its canola process, ramp up production, and fulfill customer orders in the coming months. The company has accelerated its launch and production timeline by six months due to significant customer interest.
Burcon NutraScience announced the appointment of Robert Peets as the new Chief Financial Officer (CFO), effective July 1, 2024. Peets, with over 30 years of experience in financial management and capital markets, will succeed Jade Cheng, who is stepping down for personal reasons on June 30, 2024. Peets presently serves as a fractional CFO for multiple technology companies and previously held a prominent role at TELUS Ventures. Burcon's CEO, Kip Underwood, expressed gratitude to Cheng for her significant contributions over the past 25 years and welcomed Peets, emphasizing his expertise in capital market strategies.
